• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
SenTiva DUO VNS Therapy

LivaNova introduces SenTiva DUO

LivaNova, a leading medical tech and innovation firm, launches SenTiva DUO, an IPG with dual-pin header for treatment of drug-resistant epilepsy via VNS Therapy. SenTiva DUO distinguishes itself from the original SenTiva (single-pin) and provides latest VNS Therapy technology to patients originally implanted with dual-pin lead and IPG.

Read more →